{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["antioxidants", "apigenin", "flavonoids", "intracellular signalling", "metabolic syndrome"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34679777", "DateRevised": {"Year": "2021", "Month": "10", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "10", "Day": "19"}], "Language": ["eng"], "ELocationID": ["1643", "10.3390/antiox10101643"], "Journal": {"ISSN": "2076-3921", "JournalIssue": {"Volume": "10", "Issue": "10", "PubDate": {"Year": "2021", "Month": "Oct", "Day": "19"}}, "Title": "Antioxidants (Basel, Switzerland)", "ISOAbbreviation": "Antioxidants (Basel)"}, "ArticleTitle": "Current Status and Future Perspectives on Therapeutic Potential of Apigenin: Focus on Metabolic-Syndrome-Dependent Organ Dysfunction.", "Abstract": {"AbstractText": ["Metabolic syndrome and its associated disorders such as obesity, insulin resistance, atherosclerosis and type 2 diabetes mellitus are globally prevalent. Different molecules showing therapeutic potential are currently available for the management of metabolic syndrome, although their efficacy has often been compromised by their poor bioavailability and side effects. Studies have been carried out on medicinal plant extracts for the treatment and prevention of metabolic syndrome. In this regard, isolated pure compounds have shown promising efficacy for the management of metabolic syndrome, both in preclinical and clinical settings. Apigenin, a natural bioactive flavonoid widely present in medicinal plants, functional foods, vegetables and fruits, exerts protective effects in models of neurological disorders and cardiovascular diseases and most of these effects are attributed to its antioxidant action. Various preclinical and clinical studies carried out so far show a protective effect of apigenin against metabolic syndrome. Herein, we provide a comprehensive review on both in vitro and in vivo evidence related to the promising antioxidant role of apigenin in cardioprotection, neuroprotection and renoprotection, and to its beneficial action in metabolic-syndrome-dependent organ dysfunction. We also provide evidence on the potential of apigenin in the prevention and/or treatment of metabolic syndrome, analysing the potential and limitation of its therapeutic use."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Abdul Wali Khan University Mardan, Mardan 23200, Pakistan."}], "LastName": "Alam", "ForeName": "Waqas", "Initials": "W"}, {"Identifier": ["0000-0002-1743-4724"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Cellular and Molecular Cardiovascular Physiology, Department of Biology, Ecology and Earth Sciences (Di.B.E.S.T.), University of Calabria, 87036 Rende, Italy."}], "LastName": "Rocca", "ForeName": "Carmine", "Initials": "C"}, {"Identifier": ["0000-0002-1736-4404"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Abdul Wali Khan University Mardan, Mardan 23200, Pakistan."}], "LastName": "Khan", "ForeName": "Haroon", "Initials": "H"}, {"Identifier": ["0000-0003-1054-6720"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmaceutical Sciences, Soochow University, Suzhou 221400, China."}], "LastName": "Hussain", "ForeName": "Yaseen", "Initials": "Y"}, {"Identifier": ["0000-0002-2619-1656"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Pharmacology, Albert Einstein College of Medicine, Forchheimer 209, 1300 Morris Park Avenue, Bronx, NY 10461, USA."}], "LastName": "Aschner", "ForeName": "Michael", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Cellular and Molecular Cardiovascular Physiology, Department of Biology, Ecology and Earth Sciences (Di.B.E.S.T.), University of Calabria, 87036 Rende, Italy."}], "LastName": "De Bartolo", "ForeName": "Anna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy."}], "LastName": "Amodio", "ForeName": "Nicola", "Initials": "N"}, {"Identifier": ["0000-0001-7797-7862"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Cellular and Molecular Cardiovascular Physiology, Department of Biology, Ecology and Earth Sciences (Di.B.E.S.T.), University of Calabria, 87036 Rende, Italy."}, {"Identifier": [], "Affiliation": "National Institute of Cardiovascular Research I.N.R.C., 40126 Bologna, Italy."}], "LastName": "Angelone", "ForeName": "Tommaso", "Initials": "T"}, {"Identifier": ["0000-0002-1152-7997"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China."}], "LastName": "Cheang", "ForeName": "Wai San", "Initials": "WS"}], "GrantList": [{"GrantID": "IG24449", "Agency": "Italian Association for Cancer Research", "Country": ""}, {"GrantID": "GR-2016-02361523", "Agency": "Ministero della Salute", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Antioxidants (Basel)", "NlmUniqueID": "101668981", "ISSNLinking": "2076-3921"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Salehi B., Venditti A., Sharifi-Rad M., Kr\u0119giel D., Sharifi-Rad J., Durazzo A., Lucarini M., Santini A., Souto E.B., Novellino E., et al. The Therapeutic Potential of Apigenin. Int. J. Mol. Sci. 2019;20:1305. doi: 10.3390/ijms20061305.", "ArticleIdList": ["10.3390/ijms20061305", "PMC6472148", "30875872"]}, {"Citation": "Kandola A., Ashdown-Franks G., Hendrikse J., Sabiston C.M., Stubbs B. Physical activity and depression: Towards understanding the antidepressant mechanisms of physical activity. Neurosci. Biobehav. Rev. 2019;107:525\u2013539. doi: 10.1016/j.neubiorev.2019.09.040.", "ArticleIdList": ["10.1016/j.neubiorev.2019.09.040", "31586447"]}, {"Citation": "Spence J.D. Nutrition and Risk of Stroke. Nutrients. 2019;11:647. doi: 10.3390/nu11030647.", "ArticleIdList": ["10.3390/nu11030647", "PMC6470893", "30884883"]}, {"Citation": "Kabera J.N., Semana E., Mussa A.R., He X. Plant secondary metabolites: Biosynthesis, classification, function and pharmacological properties. J. Pharm. Pharmacol. 2014;2:377\u2013392."}, {"Citation": "Amarowicz R., Carle R., Dongowski G., Durazzo A., Galensa R., Kammerer D., Maiani G., Piskula M.K. Influence of postharvest processing and storage on the content of phenolic acids and flavonoids in foods. Mol. Nutr. Food Res. 2009;53((Suppl. S2)):S151\u2013S183. doi: 10.1002/mnfr.200700486.", "ArticleIdList": ["10.1002/mnfr.200700486", "19065581"]}, {"Citation": "Falcone Ferreyra M.L., Rius S.P., Casati P. Flavonoids: Biosynthesis, biological functions, and biotechnological applications. Front. Plant Sci. 2012;3:222. doi: 10.3389/fpls.2012.00222.", "ArticleIdList": ["10.3389/fpls.2012.00222", "PMC3460232", "23060891"]}, {"Citation": "Maduni\u0107 J., Maduni\u0107 I.V., Gajski G., Popi\u0107 J., Garaj-Vrhovac V. Apigenin: A dietary flavonoid with diverse anticancer properties. Cancer Lett. 2018;413:11\u201322. doi: 10.1016/j.canlet.2017.10.041.", "ArticleIdList": ["10.1016/j.canlet.2017.10.041", "29097249"]}, {"Citation": "Ferrer J.L., Austin M.B., Stewart C., Jr., Noel J.P. Structure and function of enzymes involved in the biosynthesis of phenylpropanoids. Plant Physiol. Biochem. 2008;46:356\u2013370. doi: 10.1016/j.plaphy.2007.12.009.", "ArticleIdList": ["10.1016/j.plaphy.2007.12.009", "PMC2860624", "18272377"]}, {"Citation": "Kassi E., Pervanidou P., Kaltsas G., Chrousos G. Metabolic syndrome: Definitions and controversies. BMC Med. 2011;9:48. doi: 10.1186/1741-7015-9-48.", "ArticleIdList": ["10.1186/1741-7015-9-48", "PMC3115896", "21542944"]}, {"Citation": "Galleano M., Calabro V., Prince P.D., Litterio M.C., Piotrkowski B., Vazquez-Prieto M.A., Miatello R.M., Oteiza P.I., Fraga C.G. Flavonoids and metabolic syndrome. Ann. N. Y. Acad. Sci. 2012;1259:87\u201394. doi: 10.1111/j.1749-6632.2012.06511.x.", "ArticleIdList": ["10.1111/j.1749-6632.2012.06511.x", "22758640"]}, {"Citation": "Yang C.S., Landau J.M., Huang M.T., Newmark H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 2001;21:381\u2013406. doi: 10.1146/annurev.nutr.21.1.381.", "ArticleIdList": ["10.1146/annurev.nutr.21.1.381", "11375442"]}, {"Citation": "Hostetler G.L., Ralston R.A., Schwartz S.J. Flavones: Food Sources, Bioavailability, Metabolism, and Bioactivity. Adv. Nutr. 2017;8:423\u2013435. doi: 10.3945/an.116.012948.", "ArticleIdList": ["10.3945/an.116.012948", "PMC5421117", "28507008"]}, {"Citation": "Alberti K.G., Zimmet P., Shaw J., IDF Epidemiology Task Force Consensus Group The metabolic syndrome\u2014a new worldwide definition. Lancet. 2005;366:1059\u20131062. doi: 10.1016/S0140-6736(05)67402-8.", "ArticleIdList": ["10.1016/S0140-6736(05)67402-8", "16182882"]}, {"Citation": "Festi D., Schiumerini R., Eusebi L.H., Marasco G., Taddia M., Colecchia A. Gut microbiota and metabolic syndrome. World J. Gastroenterol. 2014;20:16079\u201316094. doi: 10.3748/wjg.v20.i43.16079.", "ArticleIdList": ["10.3748/wjg.v20.i43.16079", "PMC4239493", "25473159"]}, {"Citation": "Wang M., Firrman J., Zhang L., Arango-Argoty G., Tomasula P., Liu L., Xiao W., Yam K. Apigenin Impacts the Growth of the Gut Microbiota and Alters the Gene Expression of Enterococcus. Molecules. 2017;22:1292. doi: 10.3390/molecules22081292.", "ArticleIdList": ["10.3390/molecules22081292", "PMC6152273", "28771188"]}, {"Citation": "Wang M., Firrman J., Liu L., Yam K. A Review on Flavonoid Apigenin: Dietary Intake, ADME, Antimicrobial Effects, and Interactions with Human Gut Microbiota. Biomed Res. Int. 2019;2019:7010467. doi: 10.1155/2019/7010467.", "ArticleIdList": ["10.1155/2019/7010467", "PMC6817918", "31737673"]}, {"Citation": "Shukla S., Gupta S. Apigenin: A promising molecule for cancer prevention. Pharm. Res. 2010;27:962\u2013978. doi: 10.1007/s11095-010-0089-7.", "ArticleIdList": ["10.1007/s11095-010-0089-7", "PMC2874462", "20306120"]}, {"Citation": "Ornano L., Venditti A., Donno Y., Sanna C., Ballero M., Bianco A. Phytochemical analysis of non-volatile fraction of Artemisia caerulescens subsp. densiflora (Viv.)(Asteraceae), an endemic species of La Maddalena Archipelago (Sardinia\u2013Italy) Nat. Prod. Res. 2016;30:920\u2013925. doi: 10.1080/14786419.2015.1079189.", "ArticleIdList": ["10.1080/14786419.2015.1079189", "26327252"]}, {"Citation": "Venditti A., Maggi F., Vittori S., Papa F., Serrilli A.M., Di Cecco M., Ciaschetti G., Mandrone M., Poli F., Bianco A. Volatile compounds from Achillea tenorii (Grande) growing in the Majella National Park (Italy) Nat. Prod. Res. 2014;28:1699\u20131704. doi: 10.1080/14786419.2014.940349.", "ArticleIdList": ["10.1080/14786419.2014.940349", "25103502"]}, {"Citation": "Venditti A., Guarcini L., Bianco A., Rosselli S., Bruno M., Senatore F. Phytochemical analysis of Achillea ligustica All. from Lipari Island (Aeolian Islands) Nat. Prod. Res. 2016;30:912\u2013919. doi: 10.1080/14786419.2015.1079188.", "ArticleIdList": ["10.1080/14786419.2015.1079188", "26327332"]}, {"Citation": "Sharifi-Rad M., Nazaruk J., Polito L., Morais-Braga M.F.B., Rocha J.E., Coutinho H.D.M., Salehi B., Tabanelli G., Montanari C., Del Mar Contreras M., et al. Matricaria genus as a source of antimicrobial agents: From farm to pharmacy and food applications. Microbiol. Res. 2018;215:76\u201388. doi: 10.1016/j.micres.2018.06.010.", "ArticleIdList": ["10.1016/j.micres.2018.06.010", "30172312"]}, {"Citation": "Venditti A., Frezza C., Guarcini L., Foddai S., Serafini M., Bianco A. Phytochemical Study of a Species with Ethnopharmacological Interest: Sideritis romana L. Eur. J. Med. Plants. 2016;12:1\u20139. doi: 10.9734/EJMP/2016/23809.", "ArticleIdList": ["10.9734/EJMP/2016/23809"]}, {"Citation": "Forkmann G. Flavonoids as flower pigments: The formation of the natural spectrum and its extension by genetic engineering. Plant Breed. 1991;106:1\u201326. doi: 10.1111/j.1439-0523.1991.tb00474.x.", "ArticleIdList": ["10.1111/j.1439-0523.1991.tb00474.x"]}, {"Citation": "Herrmann K.M. The shikimate pathway as an entry to aromatic secondary metabolism. Plant Physiol. 1995;107:7\u201312. doi: 10.1104/pp.107.1.7.", "ArticleIdList": ["10.1104/pp.107.1.7", "PMC161158", "7870841"]}, {"Citation": "Martens S., Forkmann G., Matern U., Lukacin R. Cloning of parsley flavone synthase I. Phytochemistry. 2001;58:43\u201346. doi: 10.1016/S0031-9422(01)00191-1.", "ArticleIdList": ["10.1016/S0031-9422(01)00191-1", "11524111"]}, {"Citation": "Zhang J., Liu D., Huang Y., Gao Y., Qian S. Biopharmaceutics classification and intestinal absorption study of apigenin. Int. J. Pharm. 2012;436:311\u2013317. doi: 10.1016/j.ijpharm.2012.07.002.", "ArticleIdList": ["10.1016/j.ijpharm.2012.07.002", "22796171"]}, {"Citation": "Pforte H., Hempel J., Jacobasch G. Distribution pattern of a flavonoid extract in the gastrointestinal lumen and wall of rats. Nahrung. 1999;43:205\u2013208. doi: 10.1002/(SICI)1521-3803(19990601)43:3<205::AID-FOOD205>3.0.CO;2-M.", "ArticleIdList": ["10.1002/(SICI)1521-3803(19990601)43:3<205::AID-FOOD205>3.0.CO;2-M", "10399356"]}, {"Citation": "Chen J., Lin H., Hu M. Metabolism of flavonoids via enteric recycling: Role of intestinal disposition. J. Pharmacol. Exp. Ther. 2003;304:1228\u20131235. doi: 10.1124/jpet.102.046409.", "ArticleIdList": ["10.1124/jpet.102.046409", "12604700"]}, {"Citation": "Li B., Birt D.F. In vivo and in vitro percutaneous absorption of cancer preventive flavonoid apigenin in different vehicles in mouse skin. Pharm. Res. 1996;13:1710\u20131715. doi: 10.1023/A:1016453009818.", "ArticleIdList": ["10.1023/A:1016453009818", "8956339"]}, {"Citation": "Gradolatto A., Basly J.P., Berges R., Teyssier C., Chagnon M.C., Siess M.H., Canivenc-Lavier M.C. Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration. Drug Metab. Dispos. 2005;33:49\u201354. doi: 10.1124/dmd.104.000893.", "ArticleIdList": ["10.1124/dmd.104.000893", "15466493"]}, {"Citation": "Bader N., Bosy-Westphal A., Koch A., Mueller M.J. Influence of Vitamin C and E Supplementation on Oxidative Stress Induced by Hyperbaric Oxygen in Healthy Men. Ann. Nutr. Metab. 2006;50:173\u2013176. doi: 10.1159/000090737.", "ArticleIdList": ["10.1159/000090737", "16407642"]}, {"Citation": "Zhang X., Han R., Sun X., Li G., Yang Q., Li Q., Gai W., Zhang M., Chen L., Yang G., et al. The Effect of the Skeleton Structure of Flavanone and Flavonoid on Interaction with Transferrin. Bioorg. Med. Chem. Lett. 2013;23:6677\u20136681. doi: 10.1016/j.bmcl.2013.10.042.", "ArticleIdList": ["10.1016/j.bmcl.2013.10.042", "24239187"]}, {"Citation": "DeRango-Adem E.F., Blay J. Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers? Front. Pharmacol. 2021;12:681477. doi: 10.3389/fphar.2021.681477.", "ArticleIdList": ["10.3389/fphar.2021.681477", "PMC8167032", "34084146"]}, {"Citation": "Tang L., Zhou J., Yang C.H., Xia B.J., Hu M., Liu Z.Q. Systematic studies of sulfation and glucuronidation of 12 flavonoids in the mouse liver S9 fraction reveal both unique and shared positional preferences. J. Agric. Food Chem. 2012;60:3223\u20133233. doi: 10.1021/jf201987k.", "ArticleIdList": ["10.1021/jf201987k", "PMC3409651", "22352802"]}, {"Citation": "Griffiths L.A., Smith G.E. Metabolism of apigenin and related compounds in the rat. Metabolite formation in vivo and by the intestinal microflora in vitro. Biochem. J. 1972;128:901\u2013911. doi: 10.1042/bj1280901.", "ArticleIdList": ["10.1042/bj1280901", "PMC1173909", "4638796"]}, {"Citation": "Galijatovic A., Otake Y., Walle U.K., Walle T. Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells. Xenobiotica. 1999;29:1241\u20131256. doi: 10.1080/004982599237912.", "ArticleIdList": ["10.1080/004982599237912", "10647910"]}, {"Citation": "Day A.J., DuPont M.S., Ridley S., Rhodes M., Rhodes M.J., Morgan M.R., Williamson G. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett. 1998;436:71\u201375. doi: 10.1016/S0014-5793(98)01101-6.", "ArticleIdList": ["10.1016/S0014-5793(98)01101-6", "9771896"]}, {"Citation": "Tang D., Chen K., Huang L., Li J. Pharmacokinetic properties and drug interactions of apigenin, a natural flavone. Expert Opin. Drug Metab. Toxicol. 2017;13:323\u2013330. doi: 10.1080/17425255.2017.1251903.", "ArticleIdList": ["10.1080/17425255.2017.1251903", "27766890"]}, {"Citation": "Li B., Robinson D.H., Birt D.F. Evaluation of properties of apigenin and [G-3H]apigenin and analytic method development. J Pharm Sci. 1997;86:721\u2013725. doi: 10.1021/js960383s.", "ArticleIdList": ["10.1021/js960383s", "9188055"]}, {"Citation": "Ding S.M., Zhang Z.H., Song J., Cheng X.D., Jiang J., Jia X.B. Enhanced bioavailability of apigenin via preparation of a carbon nanopowder solid dispersion. Int. J. Nanomed. 2014;9:2327\u20132333. doi: 10.2147/IJN.S60938.", "ArticleIdList": ["10.2147/IJN.S60938", "PMC4026550", "24872695"]}, {"Citation": "Zhang J., Huang Y., Liu D., Gao Y., Qian S. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement. Eur. J. Pharm. Sci. 2013;48:740\u2013747. doi: 10.1016/j.ejps.2012.12.026.", "ArticleIdList": ["10.1016/j.ejps.2012.12.026", "23305994"]}, {"Citation": "Kaur J. A comprehensive review on metabolic syndrome. Cardiol. Res. Pract. 2014;2014:21. doi: 10.1155/2014/943162.", "ArticleIdList": ["10.1155/2014/943162", "PMC3966331", "24711954"]}, {"Citation": "Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C., Jr., et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735\u20132752. doi: 10.1161/CIRCULATIONAHA.105.169404.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.105.169404", "16157765"]}, {"Citation": "Padhi T.G. Metabolic syndrome and skin: Psoriasis and beyond. Indian J. Dermatol. 2013;58:299\u2013305. doi: 10.4103/0019-5154.113950.", "ArticleIdList": ["10.4103/0019-5154.113950", "PMC3726879", "23919003"]}, {"Citation": "Bruce K.D., Byrne C.D. The metabolic syndrome: Common origins of a multifactorial disorder. Postgrad. Med. J. 2009;85:614\u2013621. doi: 10.1136/pgmj.2008.078014.", "ArticleIdList": ["10.1136/pgmj.2008.078014", "19892897"]}, {"Citation": "Locatelli F., Pozzoni P., Del Vecchio L. Renal manifestations in the metabolic syndrome. J. Am. Soc. Nephrol. 2006;4((Suppl. S2)):S81\u2013S85. doi: 10.1681/ASN.2005121332.", "ArticleIdList": ["10.1681/ASN.2005121332", "16565254"]}, {"Citation": "Standl E. Aetiology and consequences of the metabolic syndrome. Eur. Heart J. Suppl. 2005;7((Suppl. D)):D10\u2013D13. doi: 10.1093/eurheartj/sui023.", "ArticleIdList": ["10.1093/eurheartj/sui023"]}, {"Citation": "Dokras A., Bochner M., Hollinrake E., Markham S., Vanvoorhis B., Jagasia D.H. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet. Gynecol. 2005;106:131\u2013137. doi: 10.1097/01.AOG.0000167408.30893.6b.", "ArticleIdList": ["10.1097/01.AOG.0000167408.30893.6b", "15994628"]}, {"Citation": "Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome\u2014a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 2006;23:469\u2013480. doi: 10.1111/j.1464-5491.2006.01858.x.", "ArticleIdList": ["10.1111/j.1464-5491.2006.01858.x", "16681555"]}, {"Citation": "Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356\u2013359. doi: 10.1001/jama.287.3.356.", "ArticleIdList": ["10.1001/jama.287.3.356", "11790215"]}, {"Citation": "Cornier M.A., Dabelea D., Hernandez T.L., Lindstrom R.C., Steig A.J., Stob N.R., Van Pelt R.E., Wang H., Eckel R.H. The Metabolic Syndrome. Endocr. Rev. 2008;29:777\u2013822. doi: 10.1210/er.2008-0024.", "ArticleIdList": ["10.1210/er.2008-0024", "PMC5393149", "18971485"]}, {"Citation": "Adjei N.K., Samkange-Zeeb F., Kebede M. Racial/ethnic differences in the prevalence and incidence of metabolic syndrome in high-income countries: A protocol for a systematic review. Syst. Rev. 2020;9:134. doi: 10.1186/s13643-020-01400-y.", "ArticleIdList": ["10.1186/s13643-020-01400-y", "PMC7282095", "32513278"]}, {"Citation": "Park Y., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., Heymsfield S.B. The Metabolic Syndrome: Prevalence and Associated Risk Factor Findings in the US Population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 2003;163:427\u2013436. doi: 10.1001/archinte.163.4.427.", "ArticleIdList": ["10.1001/archinte.163.4.427", "PMC3146257", "12588201"]}, {"Citation": "Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.C., James W.P.T., Loria C.M., Smith S.C., Jr. Harmonizing the Metabolic Syndrome. Circulation. 2009;120:1640\u20131645. doi: 10.1161/CIRCULATIONAHA.109.192644.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.109.192644", "19805654"]}, {"Citation": "Gill H., Mugo M., Whaley-Connell A., Stump C., Sowers J.R. The key role of insulin resistance in the cardiometabolic syndrome. Am. J. Med. Sci. 2005;330:290\u2013294. doi: 10.1097/00000441-200512000-00006.", "ArticleIdList": ["10.1097/00000441-200512000-00006", "16355013"]}, {"Citation": "Morse S.A., Zhang R., Thakur V., Reisin E. Hypertension and the metabolic syndrome. Am. J. Med. Sci. 2005;330:303\u2013310. doi: 10.1097/00000441-200512000-00008.", "ArticleIdList": ["10.1097/00000441-200512000-00008", "16355015"]}, {"Citation": "Brinkman A.K. Management of Type 1 Diabetes. Nurs Clin. N. Am. 2017;52:499\u2013511. doi: 10.1016/j.cnur.2017.07.001.", "ArticleIdList": ["10.1016/j.cnur.2017.07.001", "29080573"]}, {"Citation": "Hermansen K., Bohl M., Schioldan A.G. Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience. Drugs. 2016;76:41\u201374. doi: 10.1007/s40265-015-0500-0.", "ArticleIdList": ["10.1007/s40265-015-0500-0", "PMC4700065", "26607485"]}, {"Citation": "Ferrannini E., Natali A. Essential hypertension, metabolic disorders, and insulin resistance. (Pt 2)Am. Heart J. 1991;121:1274\u20131282. doi: 10.1016/0002-8703(91)90433-I.", "ArticleIdList": ["10.1016/0002-8703(91)90433-I", "2008856"]}, {"Citation": "Malhotra A., Kang B.P., Cheung S., Opawumi D., Meggs L.G. Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin I. Diabetes. 2001;50:1918\u20131926. doi: 10.2337/diabetes.50.8.1918.", "ArticleIdList": ["10.2337/diabetes.50.8.1918", "11473056"]}, {"Citation": "Zorena K., Jachimowicz-Duda O., \u015al\u0119zak D., Robakowska M., Mrugacz M. Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications. Int. J. Mol. Sci. 2020;21:3570. doi: 10.3390/ijms21103570.", "ArticleIdList": ["10.3390/ijms21103570", "PMC7278967", "32443588"]}, {"Citation": "Chait A., den Hartigh L.J. Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. Front. Cardiovasc. Med. 2020;7:22. doi: 10.3389/fcvm.2020.00022.", "ArticleIdList": ["10.3389/fcvm.2020.00022", "PMC7052117", "32158768"]}, {"Citation": "Treml J., \u0160mejkal K. Flavonoids as Potent Scavengers of Hydroxyl Radicals. Compr. Rev. Food Sci. Food Saf. 2016;15:720\u2013738. doi: 10.1111/1541-4337.12204.", "ArticleIdList": ["10.1111/1541-4337.12204", "33401843"]}, {"Citation": "Wang Y., Stevens V.L., Shah R., Peterson J.J., Dwyer J.T., Gapstur S.M., McCullough M.L. Dietary flavonoid and proanthocyanidin intakes and prostate cancer risk in a prospective cohort of US men. Am. J. Epidemiol. 2014;179:974\u2013986. doi: 10.1093/aje/kwu006.", "ArticleIdList": ["10.1093/aje/kwu006", "24567173"]}, {"Citation": "Cassidy A., O\u2019Reilly \u00c9.J., Kay C., Sampson L., Franz M., Forman J.P., Curhan G., Rimm E.B. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am. J. Clin. Nutr. 2011;93:338\u2013347. doi: 10.3945/ajcn.110.006783.", "ArticleIdList": ["10.3945/ajcn.110.006783", "PMC3021426", "21106916"]}, {"Citation": "Kim J., Lee H.J., Lee K.W. Naturally occurring phytochemicals for the prevention of Alzheimer\u2019s disease. J. Neurochem. 2010;112:1415\u20131430. doi: 10.1111/j.1471-4159.2009.06562.x.", "ArticleIdList": ["10.1111/j.1471-4159.2009.06562.x", "20050972"]}, {"Citation": "Sichel G., Corsaro C., Scalia M., Di Bilio A.J., Bonomo R.P. In vitro scavenger activity of some flavonoids and melanins against O2-(.) Free Radic. Biol. Med. 1991;11:1\u20138. doi: 10.1016/0891-5849(91)90181-2.", "ArticleIdList": ["10.1016/0891-5849(91)90181-2", "1657731"]}, {"Citation": "Han J.Y., Ahn S.Y., Kim C.S., Yoo S.K., Kim S.K., Kim H.C., Hong J.T., Oh K.W. Protection of apigenin against kainate-induced excitotoxicity by anti-oxidative effects. Biol. Pharm. Bull. 2012;35:1440\u20131446. doi: 10.1248/bpb.b110686.", "ArticleIdList": ["10.1248/bpb.b110686", "22975493"]}, {"Citation": "Yue S., Xue N., Li H., Huang B., Chen Z., Wan X. Hepatoprotective Effect of Apigenin Against Liver Injury via the Non-canonical NF-\u03baB Pathway In Vivo and In Vitro. Inflammation. 2020;43:1634\u20131648. doi: 10.1007/s10753-020-01238-5.", "ArticleIdList": ["10.1007/s10753-020-01238-5", "32458347"]}, {"Citation": "Ji J., Yu Q., Dai W., Wu L., Feng J., Zheng Y., Li Y., Guo C. Apigenin Alleviates Liver Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Autophagy via TGF-\u03b21/Smad3 and p38/PPAR\u03b1 Pathways. PPAR Res. 2021;2021:6651839. doi: 10.1155/2021/6651839.", "ArticleIdList": ["10.1155/2021/6651839", "PMC7861947", "33574836"]}, {"Citation": "Zhang X., Bu H., Jiang Y., Sun G., Jiang R., Huang X., Duan H., Huang Z., Wu Q. The antidepressant effects of apigenin are associated with the promotion of autophagy via the mTOR/AMPK/ULK1 pathway. Mol. Med. Rep. 2019;20:2867\u20132874. doi: 10.3892/mmr.2019.10491.", "ArticleIdList": ["10.3892/mmr.2019.10491", "31322238"]}, {"Citation": "Perrott K.M., Wiley C.D., Desprez P.-Y., Campisi J. Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells. Geroscience. 2017;39:161\u2013173. doi: 10.1007/s11357-017-9970-1.", "ArticleIdList": ["10.1007/s11357-017-9970-1", "PMC5411372", "28378188"]}, {"Citation": "Qin Y., Zhao D., Zhou H.-g., Wang X.-h., Zhong W.-l., Chen S., Gu W.G., Wang W., Zhang C.H., Liu Y.R., et al. Apigenin inhibits NF-\u03baB and snail signaling, EMT and metastasis in human hepatocellular carcinoma. Oncotarget. 2016;7:41421. doi: 10.18632/oncotarget.9404.", "ArticleIdList": ["10.18632/oncotarget.9404", "PMC5173069", "27203387"]}, {"Citation": "Zhang S., Liu X., Sun C., Yang J., Wang L., Liu J., Gong L., Jing Y. Apigenin Attenuates Experimental Autoimmune Myocarditis by Modulating Th1/Th2 Cytokine Balance in Mice. Inflammation. 2016;39:678\u2013686. doi: 10.1007/s10753-015-0294-y.", "ArticleIdList": ["10.1007/s10753-015-0294-y", "26658748"]}, {"Citation": "Ren K., Jiang T., Zhou H., Liang Y., Zhao G.-J. Apigenin Retards Atherogenesis by Promoting ABCA1-Mediated Cholesterol Efflux and Suppressing Inflammation. Cell Physiol. Biochem. 2018;47:2170\u20132184. doi: 10.1159/000491528.", "ArticleIdList": ["10.1159/000491528", "29975943"]}, {"Citation": "Li J.M., Zhang B.F. Apigenin protects ovalbumin-induced asthma through the regulation of Th17 cells. Fitoterapia. 2013;91:298\u2013304. doi: 10.1016/j.fitote.2013.09.009.", "ArticleIdList": ["10.1016/j.fitote.2013.09.009", "24060907"]}, {"Citation": "Goto T., Hagiwara K., Shirai N., Yoshida K., Hagiwara H. Apigenin inhibits osteoblastogenesis and osteoclastogenesis and prevents bone loss in ovariectomized mice. Cytotechnology. 2015;67:357\u2013365. doi: 10.1007/s10616-014-9694-3.", "ArticleIdList": ["10.1007/s10616-014-9694-3", "PMC4329293", "24500394"]}, {"Citation": "Lampropoulos P., Lambropoulou M., Papalois A., Basios N., Manousi M., Simopoulos C., Tsaroucha A.K. The role of apigenin in an experimental model of acute pancreatitis. J. Surg. Res. 2013;183:129\u2013137. doi: 10.1016/j.jss.2012.11.053.", "ArticleIdList": ["10.1016/j.jss.2012.11.053", "23273883"]}, {"Citation": "Mrazek A.A., Porro L.J., Bhatia V., Falzon M., Spratt H., Zhou J., Chao C., Hellmich M.R. Apigenin inhibits pancreatic stellate cell activity in pancreatitis. J. Surg. Res. 2015;196:8\u201316. doi: 10.1016/j.jss.2015.02.032.", "ArticleIdList": ["10.1016/j.jss.2015.02.032", "PMC4430404", "25799526"]}, {"Citation": "Zhou X., Wang F., Zhou R., Song X., Xie M. Apigenin: A current review on its beneficial biological activities. J. Food Biochem. 2017;41:e12376. doi: 10.1111/jfbc.12376.", "ArticleIdList": ["10.1111/jfbc.12376"]}, {"Citation": "Arango D., Morohashi K., Yilmaz A., Kuramochi K., Parihar A., Brahimaj B., Grotewold E., Doseff A.I. Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targets. Proc. Natl. Acad. Sci. USA. 2013;110:E2153\u2013E2162. doi: 10.1073/pnas.1303726110.", "ArticleIdList": ["10.1073/pnas.1303726110", "PMC3683737", "23697369"]}, {"Citation": "Forman H.J., Zhang H. Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 2021;20:689\u2013709. doi: 10.1038/s41573-021-00233-1.", "ArticleIdList": ["10.1038/s41573-021-00233-1", "PMC8243062", "34194012"]}, {"Citation": "Spahis S., Borys J.M., Levy E. Metabolic syndrome as a multifaceted risk factor for oxidative stress. Antioxid. Redox Signal. 2017;26:445\u2013461. doi: 10.1089/ars.2016.6756.", "ArticleIdList": ["10.1089/ars.2016.6756", "27302002"]}, {"Citation": "Seddon M., Looi Y.H., Shah A.M. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart. 2007;93:903\u2013907. doi: 10.1136/hrt.2005.068270.", "ArticleIdList": ["10.1136/hrt.2005.068270", "PMC1994416", "16670100"]}, {"Citation": "Rocca C., Pasqua T., Boukhzar L., Anouar Y., Angelone T. Progress in the emerging role of selenoproteins in cardiovascular disease: Focus on endoplasmic reticulum-resident selenoproteins. Cell. Mol. Life Sci. 2019;76:3969\u20133985. doi: 10.1007/s00018-019-03195-1.", "ArticleIdList": ["10.1007/s00018-019-03195-1", "31218451"]}, {"Citation": "Rocca C., Grande F., Granieri M.C., Colombo B., De Bartolo A., Giordano F., Rago V., Amodio N., Tota B., Cerra M.C., et al. The chromogranin A1-373 fragment reveals how a single change in the protein sequence exerts strong cardioregulatory effects by engaging neuropilin-1. Acta Physiol. 2021;231:e13570. doi: 10.1111/apha.13570.", "ArticleIdList": ["10.1111/apha.13570", "33073482"]}, {"Citation": "Grande F., De Bartolo A., Occhiuzzi M.A., Caruso A., Rocca C., Pasqua T., Carocci A., Rago V., Angelone T., Sinicropi M.S. Carbazole and Simplified Derivatives: Novel Tools toward \u03b2-Adrenergic Receptors Targeting. Appl. Sci. 2021;11:5486. doi: 10.3390/app11125486.", "ArticleIdList": ["10.3390/app11125486"]}, {"Citation": "Rangwala S.M., Lazar M.A. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends Pharmacol. Sci. 2004;25:331\u2013336. doi: 10.1016/j.tips.2004.03.012.", "ArticleIdList": ["10.1016/j.tips.2004.03.012", "15165749"]}, {"Citation": "Thangaiyan R., Robert B.M., Arjunan S., Govindasamy K., Nagarajan R.P. Preventive effect of apigenin against isoproterenol-induced apoptosis in cardiomyoblasts. J. Biochem. Mol. Toxicol. 2018;32:e22213. doi: 10.1002/jbt.22213.", "ArticleIdList": ["10.1002/jbt.22213", "30152906"]}, {"Citation": "Gao H.L., Yu X.J., Hu H.B., Yang Q.W., Liu K.L., Chen Y.M., Zhang Y., Zhang D.D., Tian H., Zhu G.Q., et al. Apigenin Improves Hypertension and Cardiac Hypertrophy Through Modulating NADPH Oxidase-Dependent ROS Generation and Cytokines in Hypothalamic Paraventricular Nucleus. Cardiovasc. Toxicol. 2021;21:721\u2013736. doi: 10.1007/s12012-021-09662-1.", "ArticleIdList": ["10.1007/s12012-021-09662-1", "34076830"]}, {"Citation": "Zamorano J.L., Lancellotti P., Rodriguez Mu\u00f1oz D., Aboyans V., Asteggiano R., Galderisi M., Habib G., Lenihan D.J., Lip G.Y.H., Lyon A.R., et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) Eur. Heart J. 2016;37:2768\u20132801. doi: 10.1093/eurheartj/ehw211.", "ArticleIdList": ["10.1093/eurheartj/ehw211", "27567406"]}, {"Citation": "Rocca C., Pasqua T., Cerra M.C., Angelone T. Cardiac Damage in Anthracyclines Therapy: Focus on Oxidative Stress and Inflammation. Antioxid. Redox Signal. 2020;32:1081\u20131097. doi: 10.1089/ars.2020.8016.", "ArticleIdList": ["10.1089/ars.2020.8016", "31928066"]}, {"Citation": "Zare M.F.R., Rakhshan K., Aboutaleb N., Nikbakht F., Naderi N., Bakhshesh M., Azizi Y. Apigenin attenuates doxorubicin induced cardiotoxicity via reducing oxidative stress and apoptosis in male rats. Life Sci. 2019;232:116623. doi: 10.1016/j.lfs.2019.116623.", "ArticleIdList": ["10.1016/j.lfs.2019.116623", "31279781"]}, {"Citation": "Sahu R., Dua T.K., Das S., De Feo V., Dewanjee S. Wheat phenolics suppress doxorubicin-induced cardiotoxicity via inhibition of oxidative stress, MAP kinase activation, NF-\u03baB pathway, PI3K/Akt/mTOR impairment, and cardiac apoptosis. Food Chem. Toxicol. 2019;125:503\u2013519. doi: 10.1016/j.fct.2019.01.034.", "ArticleIdList": ["10.1016/j.fct.2019.01.034", "30735749"]}, {"Citation": "Navarro-Hortal M.D., Varela-L\u00f3pez A., Romero-M\u00e1rquez J.M., Rivas-Garc\u00eda L., Speranza L., Battino M., Quiles J.L. Role of flavonoids against adriamycin toxicity. Food Chem. Toxicol. 2020;146:111820. doi: 10.1016/j.fct.2020.111820.", "ArticleIdList": ["10.1016/j.fct.2020.111820", "33080329"]}, {"Citation": "Clayton Z.S., Hutton D.A., Brunt V.E., VanDongen N.S., Ziemba B.P., Casso A.G., Greenberg N.T., Mercer A.N., Rossman M.J., Campisi J., et al. Apigenin restores endothelial function by ameliorating oxidative stress, reverses aortic stiffening, and mitigates vascular inflammation with aging. Am. J. Physiol. Heart Circ. Physiol. 2021;321:H185\u2013H196. doi: 10.1152/ajpheart.00118.2021.", "ArticleIdList": ["10.1152/ajpheart.00118.2021", "PMC8321807", "34114892"]}, {"Citation": "Huang H., Lai S., Luo Y., Wan Q., Wu Q., Wan L., Qi W., Liu J. Nutritional Preconditioning of Apigenin Alleviates Myocardial Ischemia/Reperfusion Injury via the Mitochondrial Pathway Mediated by Notch1/Hes1. Oxidative Med. Cell. Longev. 2019;2019:7973098. doi: 10.1155/2019/7973098.", "ArticleIdList": ["10.1155/2019/7973098", "PMC6446095", "31015891"]}, {"Citation": "Zhou Z., Zhang Y., Lin L., Zhou J. Apigenin suppresses the apoptosis of H9C2 rat cardiomyocytes subjected to myocardial ischemia reperfusion injury via upregulation of the PI3K/Akt pathway. Mol. Med. Rep. 2018;18:1560\u20131570. doi: 10.3892/mmr.2018.9115.", "ArticleIdList": ["10.3892/mmr.2018.9115", "PMC6072196", "29901074"]}, {"Citation": "McVeigh G.E., Cohn J.N. Endothelial dysfunction and the metabolic syndrome. Curr. Diabetes Rep. 2003;3:87\u201392. doi: 10.1007/s11892-003-0059-0.", "ArticleIdList": ["10.1007/s11892-003-0059-0", "12643151"]}, {"Citation": "Qin W., Ren B., Wang S., Liang S., He B., Shi X., Wang L., Liang J., Wu F. Apigenin and naringenin ameliorate PKC\u03b2II-associated endothelial dysfunction via regulating ROS/caspase-3 and NO pathway in endothelial cells exposed to high glucose. Vasc. Pharmacol. 2016;85:39\u201349. doi: 10.1016/j.vph.2016.07.006.", "ArticleIdList": ["10.1016/j.vph.2016.07.006", "27473516"]}, {"Citation": "Xu Q., Li Y.C., Du C., Wang L.N., Xiao Y.H. Effects of Apigenin on the Expression of LOX-1, Bcl-2, and Bax in Hyperlipidemia Rats. Chem. Biodivers. 2021;18:e2100049. doi: 10.1002/cbdv.202100049.", "ArticleIdList": ["10.1002/cbdv.202100049", "34118114"]}, {"Citation": "Mahajan U.B., Chandrayan G., Patil C.R., Arya D.S., Suchal K., Agrawal Y.O., Ojha S., Goyal S.N. The Protective Effect of Apigenin on Myocardial Injury in Diabetic Rats mediating Activation of the PPAR-\u03b3 Pathway. Int. J. Mol. Sci. 2017;18:756. doi: 10.3390/ijms18040756.", "ArticleIdList": ["10.3390/ijms18040756", "PMC5412341", "28375162"]}, {"Citation": "Maron D.J. Flavonoids for reduction of atherosclerotic risk. Curr. Atheroscler. Rep. 2004;6:73\u201378. doi: 10.1007/s11883-004-0119-1.", "ArticleIdList": ["10.1007/s11883-004-0119-1", "14662111"]}, {"Citation": "Czibik G. Complex role of the HIF system in cardiovascular biology. J. Mol. Med. 2010;88:1101\u20131111. doi: 10.1007/s00109-010-0646-x.", "ArticleIdList": ["10.1007/s00109-010-0646-x", "20574807"]}, {"Citation": "Zhu Z.Y., Gao T., Huang Y., Xue J., Xie M.L. Apigenin ameliorates hypertension-induced cardiac hypertrophy and down-regulates cardiac hypoxia inducible factor-l\u03b1 in rats. Food Funct. 2016;7:1992\u20131998. doi: 10.1039/C5FO01464F.", "ArticleIdList": ["10.1039/C5FO01464F", "26987380"]}, {"Citation": "Pasqua T., Rocca C., Giglio A., Angelone T. Cardiometabolism as an Interlocking Puzzle between the Healthy and Diseased Heart: New Frontiers in Therapeutic Applications. J. Clin. Med. 2021;10:721. doi: 10.3390/jcm10040721.", "ArticleIdList": ["10.3390/jcm10040721", "PMC7918460", "33673114"]}, {"Citation": "Liu H.J., Fan Y.L., Liao H.H., Liu Y., Chen S., Ma Z.G., Zhang N., Yang Z., Deng W., Tang Q.Z. Apigenin alleviates STZ-induced diabetic cardiomyopathy. Mol. Cell. Biochem. 2017;428:9\u201321. doi: 10.1007/s11010-016-2913-9.", "ArticleIdList": ["10.1007/s11010-016-2913-9", "28176247"]}, {"Citation": "Ohno M., Shibata C., Kishikawa T., Yoshikawa T., Takata A., Kojima K., Akanuma M., Kang Y.J., Yoshida H., Otsuka M., et al. The flavonoid apigenin improves glucose tolerance through inhibition of microRNA maturation in miRNA103 transgenic mice. Sci. Rep. 2013;3:2553. doi: 10.1038/srep02553.", "ArticleIdList": ["10.1038/srep02553", "PMC3757358", "23989853"]}, {"Citation": "Escande C., Nin V., Price N.L., Capellini V., Gomes A.P., Barbosa M.T., O\u2019Neil L., White T.A., Sinclair D.A., Chini E.N. Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: Implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes. 2013;62:1084\u20131093. doi: 10.2337/db12-1139.", "ArticleIdList": ["10.2337/db12-1139", "PMC3609577", "23172919"]}, {"Citation": "Barbosa M.T., Soares S.M., Novak C.M., Sinclair D., Levine J.A., Aksoy P., Chini E.N. The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity. FASEB J. 2007;21:3629\u20133639. doi: 10.1096/fj.07-8290com.", "ArticleIdList": ["10.1096/fj.07-8290com", "17585054"]}, {"Citation": "Yoshino J., Mills K.F., Yoon M.J., Imai S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 2011;14:528\u2013536. doi: 10.1016/j.cmet.2011.08.014.", "ArticleIdList": ["10.1016/j.cmet.2011.08.014", "PMC3204926", "21982712"]}, {"Citation": "Nabavi S.F., Khan H., D\u2019onofrio G., \u0160amec D., Shirooie S., Dehpour A.R., Arg\u00fcelles S., Habtemariam S., Sobarzo-Sanchez E. Apigenin as neuroprotective agent: Of mice and men. Pharmacol. Res. 2018;128:359\u2013365. doi: 10.1016/j.phrs.2017.10.008.", "ArticleIdList": ["10.1016/j.phrs.2017.10.008", "29055745"]}, {"Citation": "Shao C., Yuan J., Liu Y., Qin Y., Wang X., Gu J., Chen G., Zhang B., Liu H.K., Zhao J., et al. Epileptic brain fluorescent imaging reveals apigenin can relieve the myeloperoxidase-mediated oxidative stress and inhibit ferroptosis. Proc. Natl. Acad. Sci. USA. 2020;117:10155\u201310164. doi: 10.1073/pnas.1917946117.", "ArticleIdList": ["10.1073/pnas.1917946117", "PMC7229752", "32327603"]}, {"Citation": "Obermeier B., Daneman R., Ransohoff R.M. Development, maintenance and disruption of the blood-brain barrier. Nat. Med. 2013;19:1584\u20131596. doi: 10.1038/nm.3407.", "ArticleIdList": ["10.1038/nm.3407", "PMC4080800", "24309662"]}, {"Citation": "Butterfield D.A., Drake J., Pocernich C., Castegna A. Evidence of oxidative damage in Alzheimer\u2019s disease brain: Central role for amyloid beta-peptide. Trends Mol. Med. 2001;7:548\u2013554. doi: 10.1016/S1471-4914(01)02173-6.", "ArticleIdList": ["10.1016/S1471-4914(01)02173-6", "11733217"]}, {"Citation": "Pang Q., Zhao Y., Chen X., Zhao K., Zhai Q., Tu F. Apigenin Protects the Brain against Ischemia/Reperfusion Injury via Caveolin-1/VEGF In Vitro and In Vivo. Oxidative Med. Cell. Longev. 2018;2018:7017204. doi: 10.1155/2018/7017204.", "ArticleIdList": ["10.1155/2018/7017204", "PMC6304859", "30622670"]}, {"Citation": "Cai M., Ma Y., Zhang W., Wang S., Wang Y., Tian L., Peng Z., Wang H., Qingrong T. Apigenin-7-O-\u03b2-D-(-6\u2033-p-coumaroyl)-Glucopyranoside Treatment Elicits Neuroprotective Effect against Experimental Ischemic Stroke. Int. J. Biol. Sci. 2016;12:42\u201352. doi: 10.7150/ijbs.12275.", "ArticleIdList": ["10.7150/ijbs.12275", "PMC4679397", "26722216"]}, {"Citation": "Han Y., Zhang T., Su J., Zhao Y., Chenchen Wang Li X. Apigenin attenuates oxidative stress and neuronal apoptosis in early brain injury following subarachnoid hemorrhage. J. Clin. Neurosci. 2017;40:157\u2013162. doi: 10.1016/j.jocn.2017.03.003.", "ArticleIdList": ["10.1016/j.jocn.2017.03.003", "28342702"]}, {"Citation": "Tu F., Pang Q., Huang T., Zhao Y., Liu M., Chen X. Apigenin Ameliorates Post-Stroke Cognitive Deficits in Rats through Histone Acetylation-Mediated Neurochemical Alterations. Med. Sci. Monit. 2017;23:4004\u20134013. doi: 10.12659/MSM.902770.", "ArticleIdList": ["10.12659/MSM.902770", "PMC5572783", "28821706"]}, {"Citation": "Kalivarathan J., Chandrasekaran S.P., Kalaivanan K., Ramachandran V., Carani Venkatraman A. Apigenin attenuates hippocampal oxidative events, inflammation and pathological alterations in rats fed high fat, fructose diet. Biomed. Pharmacother. 2017;89:323\u2013331. doi: 10.1016/j.biopha.2017.01.162.", "ArticleIdList": ["10.1016/j.biopha.2017.01.162", "28237914"]}, {"Citation": "Araki E., Inagaki N., Tanizawa Y., Oura T., Takeuchi M., Imaoka T. Efficacy and safety of once-weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once-daily insulin glargine in Japanese patients with type 2 diabetes: A randomized, open-label, phase III, non-inferiority study. Diabetes Obes. Metab. 2015;17:994\u20131002. doi: 10.1111/dom.12540.", "ArticleIdList": ["10.1111/dom.12540", "PMC5042081", "26179754"]}, {"Citation": "Pabla N., Dong Z. Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies. Kidney Int. 2008;73:994\u20131007. doi: 10.1038/sj.ki.5002786.", "ArticleIdList": ["10.1038/sj.ki.5002786", "18272962"]}, {"Citation": "Hassan S.M., Khalaf M.M., Sadek S.A., Abo-Youssef A.M. Protective effects of apigenin and myricetin against cisplatin-induced nephrotoxicity in mice. Pharm. Biol. 2017;55:766\u2013774. doi: 10.1080/13880209.2016.1275704.", "ArticleIdList": ["10.1080/13880209.2016.1275704", "PMC6130592", "28064632"]}, {"Citation": "Wu Q., Li W., Zhao J., Sun W., Yang Q., Chen C., Xia P., Zhu J., Zhou Y., Huang G., et al. Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation. Biomed. Pharmacother. 2021;137:111308. doi: 10.1016/j.biopha.2021.111308.", "ArticleIdList": ["10.1016/j.biopha.2021.111308", "33556877"]}, {"Citation": "He X., Li C., Wei Z., Wang J., Kou J., Liu W., Shi M., Yang Z., Fu Y. Protective role of apigenin in cisplatin-induced renal injury. Eur. J. Pharmacol. 2016;789:215\u2013221. doi: 10.1016/j.ejphar.2016.07.003.", "ArticleIdList": ["10.1016/j.ejphar.2016.07.003", "27388142"]}, {"Citation": "Liu Y., Wang L., Du Y., Chen Z., Guo J., Weng X., Wang X., Wang M., Chen D., Liu X. Effects of apigenin pretreatment against renal ischemia/reperfusion injury via activation of the JAK2/STAT3 pathway. Biomed. Pharmacother. 2017;95:1799\u20131808. doi: 10.1016/j.biopha.2017.09.091.", "ArticleIdList": ["10.1016/j.biopha.2017.09.091", "28962085"]}, {"Citation": "Wang T., Zhang Z., Xie M., Li S., Zhang J., Zhou J. Apigenin Attenuates Mesoporous Silica Nanoparticles-Induced Nephrotoxicity by Activating FOXO3a. Biol. Trace Elem. Res. 2021 doi: 10.1007/s12011-021-02871-3.", "ArticleIdList": ["10.1007/s12011-021-02871-3", "34448149"]}, {"Citation": "Hozayen W.G., Mahmoud A.M., Desouky E.M., El-Nahass E.S., Soliman H.A., Farghali A.A. Cardiac and pulmonary toxicity of mesoporous silica nanoparticles is associated with excessive ROS production and redox imbalance in Wistar rats. Biomed. Pharmacother. 2019;109:2527\u20132538. doi: 10.1016/j.biopha.2018.11.093.", "ArticleIdList": ["10.1016/j.biopha.2018.11.093", "30551513"]}, {"Citation": "Ali A.A., Mansour A.B., Attia S.A. The potential protective role of apigenin against oxidative damage induced by nickel oxide nanoparticles in liver and kidney of male Wistar rat, Rattus norvegicus. Environ. Sci. Pollut. Res. Int. 2021;28:27577\u201327592. doi: 10.1007/s11356-021-12632-3.", "ArticleIdList": ["10.1007/s11356-021-12632-3", "33515148"]}, {"Citation": "Zamani F., Samiei F., Mousavi Z., Azari M.R., Seydi E., Pourahmad J. Apigenin ameliorates oxidative stress and mitochondrial damage induced by multiwall carbon nanotubes in rat kidney mitochondria. J. Biochem. Mol. Toxicol. 2021;35:1\u20137. doi: 10.1002/jbt.22762.", "ArticleIdList": ["10.1002/jbt.22762", "33724625"]}, {"Citation": "Pamunuwa G., Karunaratne D.N., Waisundara V.Y. Antidiabetic Properties, Bioactive Constituents, and Other Therapeutic Effects of Scoparia dulcis. Evid. -Based Complementary Altern. Med. 2016;2016:8243215. doi: 10.1155/2016/8243215.", "ArticleIdList": ["10.1155/2016/8243215", "PMC4995349", "27594892"]}, {"Citation": "Malik S., Suchal K., Khan S.I., Bhatia J., Kishore K., Dinda A.K., Arya D.S. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-\u03baB-TNF-\u03b1 and TGF-\u03b21-MAPK-fibronectin pathways. Am. J. Physiol. Renal Physiol. 2017;313:F414\u2013F422. doi: 10.1152/ajprenal.00393.2016.", "ArticleIdList": ["10.1152/ajprenal.00393.2016", "28566504"]}, {"Citation": "Hu C., Sun L., Xiao L., Han Y., Fu X., Xiong X., Xu X., Liu Y., Yang S., Liu F., et al. Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy. Curr. Med. Chem. 2015;22:2858\u20132870. doi: 10.2174/0929867322666150625095407.", "ArticleIdList": ["10.2174/0929867322666150625095407", "PMC4863711", "26119175"]}, {"Citation": "Rains J.L., Jain S.K. Oxidative stress, insulin signaling, and diabetes. Free Radic. Biol. Med. 2011;50:567\u2013575. doi: 10.1016/j.freeradbiomed.2010.12.006.", "ArticleIdList": ["10.1016/j.freeradbiomed.2010.12.006", "PMC3557825", "21163346"]}, {"Citation": "Ogura Y., Kitada M., Xu J., Monno I., Koya D. CD38 inhibition by apigenin ameliorates mitochondrial oxidative stress through restoration of the intracellular NAD+/NADH ratio and Sirt3 activity in renal tubular cells in diabetic rats. Aging. 2020;12:11325\u201311336. doi: 10.18632/aging.103410.", "ArticleIdList": ["10.18632/aging.103410", "PMC7343471", "32507768"]}, {"Citation": "Basciano H., Federico L., Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr. Metab. 2005;2:5. doi: 10.1186/1743-7075-2-5.", "ArticleIdList": ["10.1186/1743-7075-2-5", "PMC552336", "15723702"]}, {"Citation": "Mellor K., Ritchie R.H., Meredith G., Woodman O.L., Morris M.J., Delbridge L.M. High-fructose diet elevates myocardial superoxide generation in mice in the absence of cardiac hypertrophy. Nutrition. 2010;26:842\u2013848. doi: 10.1016/j.nut.2009.08.017.", "ArticleIdList": ["10.1016/j.nut.2009.08.017", "19932004"]}, {"Citation": "Yang M., Jiang Z.H., Li C.G., Zhu Y.J., Li Z., Tang Y.Z., Ni C.L. Apigenin prevents metabolic syndrome in high-fructose diet-fed mice by Keap1-Nrf2 pathway. Biomed. Pharmacother. 2018;105:1283\u20131290. doi: 10.1016/j.biopha.2018.06.108.", "ArticleIdList": ["10.1016/j.biopha.2018.06.108", "30021365"]}, {"Citation": "Herman M.A., Samuel V.T. The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis. Trends Endocrinol. Metab. 2016;27:719\u2013730. doi: 10.1016/j.tem.2016.06.005.", "ArticleIdList": ["10.1016/j.tem.2016.06.005", "PMC5035631", "27387598"]}, {"Citation": "Jung U.J., Cho Y.Y., Choi M.S. Apigenin Ameliorates Dyslipidemia, Hepatic Steatosis and Insulin Resistance by Modulating Metabolic and Transcriptional Profiles in the Liver of High-Fat Diet-Induced Obese Mice. Nutrients. 2016;8:305. doi: 10.3390/nu8050305.", "ArticleIdList": ["10.3390/nu8050305", "PMC4882717", "27213439"]}, {"Citation": "Ceriello A., Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 2004;24:816\u2013823. doi: 10.1161/01.ATV.0000122852.22604.78.", "ArticleIdList": ["10.1161/01.ATV.0000122852.22604.78", "14976002"]}, {"Citation": "Ford E.S., Mokdad A.H., Giles W.H., Brown D.W. The metabolic syndrome and antioxidant concentrations: Findings from the Third National Health and Nutrition Examination Survey. Diabetes. 2003;52:2346\u20132352. doi: 10.2337/diabetes.52.9.2346.", "ArticleIdList": ["10.2337/diabetes.52.9.2346", "12941775"]}, {"Citation": "Evans J.L., Maddux B.A., Goldfine I.D. The molecular basis for oxidative stress-induced insulin resistance. Antioxid. Redox Signal. 2005;7:1040\u20131052. doi: 10.1089/ars.2005.7.1040.", "ArticleIdList": ["10.1089/ars.2005.7.1040", "15998259"]}, {"Citation": "Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440:944\u2013948. doi: 10.1038/nature04634.", "ArticleIdList": ["10.1038/nature04634", "16612386"]}, {"Citation": "Zhang K., Song W., Li D., Jin X. Apigenin in the regulation of cholesterol metabolism and protection of blood vessels. Exp. Ther. Med. 2017;13:1719\u20131724. doi: 10.3892/etm.2017.4165.", "ArticleIdList": ["10.3892/etm.2017.4165", "PMC5443212", "28565758"]}, {"Citation": "Peng S., Hou Y., Yao J., Fang J. Activation of Nrf2-driven antioxidant enzymes by cardamonin confers neuroprotection of PC12 cells against oxidative damage. Food Funct. 2017;8:997\u20131007. doi: 10.1039/C7FO00054E.", "ArticleIdList": ["10.1039/C7FO00054E", "28271112"]}, {"Citation": "Peng S., Yao J., Liu Y., Duan D., Zhang X., Fang J. Activation of Nrf2 target enzymes conferring protection against oxidative stress in PC12 cells by ginger principal constituent 6-shogaol. Food Funct. 2015;6:2813\u20132823. doi: 10.1039/C5FO00214A.", "ArticleIdList": ["10.1039/C5FO00214A", "26169810"]}, {"Citation": "Bhakkiyalakshmi E., Dineshkumar K., Karthik S., Sireesh D., Hopper W., Paulmurugan R., Ramkumar K.M. Pterostilbene-mediated Nrf2 activation: Mechanistic insights on Keap1:Nrf2 interface. Bioorganic Med. Chem. 2016;24:3378\u20133386. doi: 10.1016/j.bmc.2016.05.011.", "ArticleIdList": ["10.1016/j.bmc.2016.05.011", "27312421"]}, {"Citation": "Bello M., Morales-Gonz\u00e1lez J.A. Molecular recognition between potential natural inhibitors of the Keap1-Nrf2 complex. (Pt 1)Int. J. Biol. Macromol. 2017;105:981\u2013992. doi: 10.1016/j.ijbiomac.2017.07.117.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.07.117", "28746889"]}, {"Citation": "Bai P., Cant\u00f3 C., Oudart H., Bruny\u00e1nszki A., Cen Y., Thomas C., Yamamoto H., Huber A., Kiss B., Houtkooper R.H., et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 2011;13:461\u2013468. doi: 10.1016/j.cmet.2011.03.004.", "ArticleIdList": ["10.1016/j.cmet.2011.03.004", "PMC3086520", "21459330"]}, {"Citation": "Aksoy P., White T.A., Thompson M., Chini E.N. Regulation of intracellular levels of NAD: A novel role for CD38. Biochem. Biophys. Res. Commun. 2006;345:1386\u20131392. doi: 10.1016/j.bbrc.2006.05.042.", "ArticleIdList": ["10.1016/j.bbrc.2006.05.042", "16730329"]}, {"Citation": "Barthel A., Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am. J. Physiol. Endocrinol. Metab. 2003;285:E685\u2013E692. doi: 10.1152/ajpendo.00253.2003.", "ArticleIdList": ["10.1152/ajpendo.00253.2003", "12959935"]}, {"Citation": "Casacchia T., Scavello F., Rocca C., Granieri M.C., Beretta G., Amelio D., Gelmini F., Spena A., Mazza R., Toma C.C., et al. Leopoldia comosa prevents metabolic disorders in rats with high-fat diet-induced obesity. Eur. J. Nutr. 2019;58:965\u2013979. doi: 10.1007/s00394-018-1609-1.", "ArticleIdList": ["10.1007/s00394-018-1609-1", "29327229"]}, {"Citation": "Cazarolli L.H., Folador P., Moresco H.H., Brighente I.M., Pizzolatti M.G., Silva F.R. Mechanism of action of the stimulatory effect of apigenin-6-C-(2\u2033-O-alpha-l-rhamnopyranosyl)-beta-L-fucopyranoside on 14C-glucose uptake. Chem.-Biol. Interact. 2009;179:407\u2013412. doi: 10.1016/j.cbi.2008.11.012.", "ArticleIdList": ["10.1016/j.cbi.2008.11.012", "19070612"]}, {"Citation": "Wang N., Yi W.J., Tan L., Zhang J.H., Xu J., Chen Y., Qin M., Yu S., Guan J., Zhang R. Apigenin attenuates streptozotocin-induced pancreatic \u03b2 cell damage by its protective effects on cellular antioxidant defense. In Vitro Cell Dev. Biol. Anim. 2017;53:554\u2013563. doi: 10.1007/s11626-017-0135-4.", "ArticleIdList": ["10.1007/s11626-017-0135-4", "28181104"]}, {"Citation": "Feng X., Yu W., Li X., Zhou F., Zhang W., Shen Q., Li J., Zhang C., Shen P. Apigenin, a modulator of PPAR\u03b3, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation. Biochem. Pharmacol. 2017;136:136\u2013149. doi: 10.1016/j.bcp.2017.04.014.", "ArticleIdList": ["10.1016/j.bcp.2017.04.014", "28414138"]}, {"Citation": "Feng X., Weng D., Zhou F., Owen Y.D., Qin H., Zhao J., Wen Y., Huang Y., Chen J., Fu H., et al. Activation of PPAR\u03b3 by a Natural Flavonoid Modulator, Apigenin Ameliorates Obesity-Related Inflammation Via Regulation of Macrophage Polarization. EBioMedicine. 2016;9:61\u201376. doi: 10.1016/j.ebiom.2016.06.017.", "ArticleIdList": ["10.1016/j.ebiom.2016.06.017", "PMC4972579", "27374313"]}, {"Citation": "Machado M.V., Michelotti G.A., Xie G., Almeida Pereira T., Boursier J., Bohnic B., Guy C.D., Diehl A.M. Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease. PLoS ONE. 2015;10:e0127991. doi: 10.1371/journal.pone.0127991.", "ArticleIdList": ["10.1371/journal.pone.0127991", "PMC4446215", "26017539"]}, {"Citation": "Tailleux A., Wouters K., Staels B. Roles of PPARs in NAFLD: Potential therapeutic targets. Biochim. Biophys. Acta. 2012;1821:809\u2013818. doi: 10.1016/j.bbalip.2011.10.016.", "ArticleIdList": ["10.1016/j.bbalip.2011.10.016", "22056763"]}, {"Citation": "Cipolletta D., Feuerer M., Li A., Kamei N., Lee J., Shoelson S.E., Benoist C., Mathis D. PPAR-\u03b3 is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature. 2012;486:549\u2013553. doi: 10.1038/nature11132.", "ArticleIdList": ["10.1038/nature11132", "PMC3387339", "22722857"]}, {"Citation": "Bouhlel M.A., Derudas B., Rigamonti E., Di\u00e8vart R., Brozek J., Haulon S., Zawadzki C., Jude B., Torpier G., Marx N., et al. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 2007;6:137\u2013143. doi: 10.1016/j.cmet.2007.06.010.", "ArticleIdList": ["10.1016/j.cmet.2007.06.010", "17681149"]}, {"Citation": "Chinetti-Gbaguidi G., Staels B. Macrophage polarization in metabolic disorders: Functions and regulation. Curr. Opin. Lipidol. 2011;22:365\u2013372. doi: 10.1097/MOL.0b013e32834a77b4.", "ArticleIdList": ["10.1097/MOL.0b013e32834a77b4", "PMC3565956", "21825981"]}, {"Citation": "Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677\u2013686. doi: 10.1016/j.it.2004.09.015.", "ArticleIdList": ["10.1016/j.it.2004.09.015", "15530839"]}, {"Citation": "Guevara I., Iwanejko J., Dembi\u0144ska-Kie\u0107 A., Pankiewicz J., Wanat A., Anna P., Go\u0142abek I., Bartu\u015b S., Malczewska-Malec M., Szczudlik A. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin. Chim. Acta. 1998;274:177\u2013188. doi: 10.1016/S0009-8981(98)00060-6.", "ArticleIdList": ["10.1016/S0009-8981(98)00060-6", "9694586"]}, {"Citation": "Salam N.K., Huang T.H., Kota B.P., Kim M.S., Li Y., Hibbs D.E. Novel PPAR-gamma agonists identified from a natural product library: A virtual screening, induced-fit docking and biological assay study. Chem. Biol. Drug Des. 2008;71:57\u201370. doi: 10.1111/j.1747-0285.2007.00606.x.", "ArticleIdList": ["10.1111/j.1747-0285.2007.00606.x", "18086153"]}, {"Citation": "Zhang T., Yamamoto N., Yamashita Y., Ashida H. The chalcones cardamonin and flavokawain B inhibit the differentiation of preadipocytes to adipocytes by activating ERK. Arch Biochem. Biophys. 2014;554:44\u201354. doi: 10.1016/j.abb.2014.05.008.", "ArticleIdList": ["10.1016/j.abb.2014.05.008", "24845100"]}, {"Citation": "Boschi F., Rizzatti V., Zamboni M., Sbarbati A. Lipid droplets fusion in adipocyte differentiated 3T3-L1 cells: A Monte Carlo simulation. Exp. Cell Res. 2014;321:201\u2013208. doi: 10.1016/j.yexcr.2013.12.023.", "ArticleIdList": ["10.1016/j.yexcr.2013.12.023", "24394544"]}, {"Citation": "Guo X., Liu J., Cai S., Wang O., Ji B. Synergistic interactions of apigenin, naringin, quercetin and emodin on inhibition of 3T3-L1 preadipocyte differentiation and pancreas lipase activity. Obes. Res. Clin. Pract. 2016;10:327\u2013339. doi: 10.1016/j.orcp.2015.08.004.", "ArticleIdList": ["10.1016/j.orcp.2015.08.004", "26314502"]}, {"Citation": "Chilloux J., Dumas M.E. Are Gut Microbes Responsible for Post-dieting Weight Rebound? Cell Metab. 2017;25:6\u20137. doi: 10.1016/j.cmet.2016.12.016.", "ArticleIdList": ["10.1016/j.cmet.2016.12.016", "28076766"]}, {"Citation": "Wu L., Guo T., Deng R., Liu L., Yu Y. Apigenin Ameliorates Insulin Resistance and Lipid Accumulation by Endoplasmic Reticulum Stress and SREBP-1c/SREBP-2 Pathway in Palmitate-Induced HepG2 Cells and High-Fat Diet-Fed Mice. J. Pharmacol. Exp. Ther. 2021;377:146\u2013156. doi: 10.1124/jpet.120.000162.", "ArticleIdList": ["10.1124/jpet.120.000162", "33509902"]}, {"Citation": "Shuster A., Patlas M., Pinthus J.H., Mourtzakis M. The clinical importance of visceral adiposity: A critical review of methods for visceral adipose tissue analysis. Br. J. Radiol. 2012;85:1\u201310. doi: 10.1259/bjr/38447238.", "ArticleIdList": ["10.1259/bjr/38447238", "PMC3473928", "21937614"]}, {"Citation": "Bouchi R., Takeuchi T., Akihisa M., Ohara N., Nakano Y., Nishitani R., Murakami M., Fukuda D., Fujita M., Minami I., et al. High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetes. Cardiovasc. Diabetol. 2015;14:136. doi: 10.1186/s12933-015-0302-4.", "ArticleIdList": ["10.1186/s12933-015-0302-4", "PMC4597374", "26445876"]}, {"Citation": "Priceman S.J., Kujawski M., Shen S., Cherryholmes G.A., Lee H., Zhang C., Kruper L., Mortimer J., Jove R., Riggs A.D., et al. Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance. Proc. Natl. Acad. Sci. USA. 2013;110:13079\u201313084. doi: 10.1073/pnas.1311557110.", "ArticleIdList": ["10.1073/pnas.1311557110", "PMC3740863", "23878227"]}, {"Citation": "Liu M., Tso P., Woods S.C. Receptor CD36 links a risk-associated allele to obesity and metabolic disorders. J. Biol. Chem. 2018;293:13349\u201313350. doi: 10.1074/jbc.H118.004818.", "ArticleIdList": ["10.1074/jbc.H118.004818", "PMC6109921", "30143599"]}, {"Citation": "Tao S., Chunhua H., Chunfang Y., Ting J., Junfang S., Minting C., Sarwat F., Ruihong G., Xianjing H., Zhaoxiang B., et al. Apigenin inhibits STAT3/CD36 signaling axis and reduces visceral obesity. Pharmacol. Res. 2020;152:104586.", "ArticleIdList": ["31877350"]}, {"Citation": "Dasu M.R., Park S., Devaraj S., Jialal I. Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice. Endocrinology. 2009;150:3457\u20133464. doi: 10.1210/en.2008-1757.", "ArticleIdList": ["10.1210/en.2008-1757", "PMC2717888", "19389833"]}, {"Citation": "Yang W.S., Jeng C.Y., Wu T.J., Tanaka S., Funahashi T., Matsuzawa Y., Wang J.P., Chen C.L., Tai T.Y., Chuang L.M. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care. 2002;25:376\u2013380. doi: 10.2337/diacare.25.2.376.", "ArticleIdList": ["10.2337/diacare.25.2.376", "11815513"]}, {"Citation": "Lehrke M., Lazar M.A. The many faces of PPARgamma. Cell. 2005;123:993\u2013999. doi: 10.1016/j.cell.2005.11.026.", "ArticleIdList": ["10.1016/j.cell.2005.11.026", "16360030"]}, {"Citation": "Nicholas C., Batra S., Vargo M.A., Voss O.H., Gavrilin M.A., Wewers M.D., Guttridge D.C., Grotewold E., Doseff A.I. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation. J. Immunol. 2007;179:7121\u20137127. doi: 10.4049/jimmunol.179.10.7121.", "ArticleIdList": ["10.4049/jimmunol.179.10.7121", "17982104"]}, {"Citation": "Andrade L.M., Andrade C.J., Dias M., Nascimento C.A.O., Mendes M.A. Chlorella and spirulina microalgae as sources of functional foods, nutraceuticals, and food supplements; an overview. MOJ Food Process Technol. 2018;6:45\u201358. doi: 10.15406/mojfpt.2018.06.00144.", "ArticleIdList": ["10.15406/mojfpt.2018.06.00144"]}, {"Citation": "Zuin V.G., Ramin L.Z. Green and Sustainable Separation of Natural Products from Agro-Industrial Waste: Challenges, Potentialities, and Perspectives on Emerging Approaches. Top. Curr. Chem. 2018;376:3. doi: 10.1007/s41061-017-0182-z.", "ArticleIdList": ["10.1007/s41061-017-0182-z", "PMC5772139", "29344754"]}, {"Citation": "Shoubaky G.A.E., Abdel-Daim M.M., Mansour M.H., Salem E.A. Isolation and Identification of a Flavone Apigenin from Marine Red Alga Acanthophora spicifera with Antinociceptive and Anti- Inflammatory Activities. J. Exp. Neurosci. 2016;10:21\u201329. doi: 10.4137/JEN.S25096.", "ArticleIdList": ["10.4137/JEN.S25096", "PMC4760667", "26917974"]}, {"Citation": "Nguyen V.T. Recovering Bioactive Compounds from Agricultural Wastes. John Wiley & Sons, Ltd.; Hoboken, NJ, USA: 2017. Potential, uses and future perspectives of agricultural wastes; pp. 1\u201332.", "ArticleIdList": ["10.1002/9781119168850.ch1"]}, {"Citation": "Lucarini M., Durazzo A., Romani A., Campo M., Lombardi-Boccia G., Cecchini F. Bio-Based Compounds from Grape Seeds: A Biorefinery Approach. Molecules. 2018;23:1888. doi: 10.3390/molecules23081888.", "ArticleIdList": ["10.3390/molecules23081888", "PMC6222734", "30060557"]}, {"Citation": "Singh P., Mishra S.K., Noel S., Sharma S., Rath S.K. Acute exposure of apigenin induces hepatotoxicity in Swiss mice. PLoS ONE. 2012;7:e31964. doi: 10.1371/journal.pone.0031964.", "ArticleIdList": ["10.1371/journal.pone.0031964", "PMC3281105", "22359648"]}, {"Citation": "Viola H., Wasowski C., Levi de Stein M., Wolfman C., Silveira R., Dajas F., Medina J.H., Paladini A.C. Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Med. 1995;61:213\u2013216. doi: 10.1055/s-2006-958058.", "ArticleIdList": ["10.1055/s-2006-958058", "7617761"]}, {"Citation": "Venigalla M., Gyengesi E., M\u00fcnch G. Curcumin and Apigenin\u2014novel and promising therapeutics against chronic neuroinflammation in Alzheimer\u2019s disease. Neural Regen. Res. 2015;10:1181\u20131185.", "ArticleIdList": ["PMC4590215", "26487830"]}, {"Citation": "Ross J.A., Kasum C.M. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 2002;22:19\u201334. doi: 10.1146/annurev.nutr.22.111401.144957.", "ArticleIdList": ["10.1146/annurev.nutr.22.111401.144957", "12055336"]}, {"Citation": "Huang Y., Zhao X., Zu Y., Wang L., Deng Y., Wu M., Wang H. Enhanced Solubility and Bioavailability of Apigenin via Preparation of Solid Dispersions of Mesoporous Silica Nanoparticles. Iran. J. Pharm. Res. 2019;18:168\u2013182.", "ArticleIdList": ["PMC6487423", "31089353"]}, {"Citation": "Calton E.K., James A.P., Pannu P.K., Soares M.J. Certain dietary patterns are beneficial for the metabolic syndrome: Reviewing the evidence. Nutr. Res. 2014;34:559\u2013568. doi: 10.1016/j.nutres.2014.06.012.", "ArticleIdList": ["10.1016/j.nutres.2014.06.012", "25150114"]}, {"Citation": "De Felice S.L. The nutraceutical revolution: Its impact on food industry R& D. Trends Food Sci. Technol. 1995;6:59\u201361."}, {"Citation": "Santini A., Novellino E. Nutraceuticals: Beyond the diet before the drugs. Curr. Bioact. Compd. 2014;10:1\u201312. doi: 10.2174/157340721001140724145924.", "ArticleIdList": ["10.2174/157340721001140724145924"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "9", "Day": "20"}, {"Year": "2021", "Month": "10", "Day": "13"}, {"Year": "2021", "Month": "10", "Day": "15"}, {"Year": "2021", "Month": "10", "Day": "23", "Hour": "1", "Minute": "2"}, {"Year": "2021", "Month": "10", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "10", "Day": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["34679777", "PMC8533599", "10.3390/antiox10101643", "antiox10101643"]}}], "PubmedBookArticle": []}